TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1969-01-01

Employees: 1K

Market Cap: -

Website: http://www.ttuhsc.edu

Clinical Trials

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Phase 4

Completed

Conditions: Obesity
Breast Cancer

Interventions: Drug: Doxorubicin
Drug: Cyclophosphamide

First Posted Date: 2012-02-22

Last Posted Date: 2018-08-22

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 15

Registration Number: NCT01537029

Locations: 🇺🇸
University of Texas Southwestern, Dallas, Texas, United States

Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

Phase 2

Completed

Conditions: Respiratory Tract Diseases
Lung Diseases
Lung Diseases, Interstitial
Pulmonary Fibrosis

First Posted Date: 2011-09-29

Last Posted Date: 2012-04-20

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 18

Registration Number: NCT01442779

Locations: 🇺🇸
Texas Tech University Health Sciences Center, Lubbock, Texas, United States

Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes

Not Applicable

Withdrawn

Conditions: Diabetic Nephropathy
Endothelial Dysfunction

Interventions: Dietary Supplement: flavonoids

First Posted Date: 2011-03-03

Last Posted Date: 2012-12-17

Lead Sponsor: Texas Tech University Health Sciences Center

Registration Number: NCT01307917

Locations: 🇺🇸
Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, United States

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Phase 4

Completed

Conditions: Obesity
Mycoses

Interventions: Drug: Anidulafungin

First Posted Date: 2011-03-03

Last Posted Date: 2019-01-09

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 20

Registration Number: NCT01307930

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Effect of Vitamin D Replacement on Insulin Sensitivity

Phase 1

Completed

Conditions: Insulin Sensitivity

Interventions: Drug: Ergocalciferols
Drug: Placebo

First Posted Date: 2010-12-29

Last Posted Date: 2015-06-08

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 12

Registration Number: NCT01268111

Locations: 🇺🇸
Texas Tech University Health Sciences Center, Odessa, Texas, United States

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations

Phase 4

Completed

Conditions: Pharmacokinetics
MRSA
Obesity
Tuberculosis
PCP

Interventions: Drug: Sulfamethoxazole/trimethoprim

First Posted Date: 2010-07-22

Last Posted Date: 2017-06-14

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 36

Registration Number: NCT01167452

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Effect of Weight and/or Obesity on Dapsone Drug Concentrations

Phase 4

Completed

Conditions: Obesity
Tuberculosis
Leprosy

Interventions: Drug: Dapsone

First Posted Date: 2010-07-20

Last Posted Date: 2016-07-21

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 37

Registration Number: NCT01165840

Locations: 🇺🇸
University of Texas Southwestern, Dallas, Texas, United States

Cytology Study of Cells From Patients With Low Back Pain

Terminated

Conditions: Back Pain

First Posted Date: 2010-03-18

Last Posted Date: 2020-01-06

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 605

Registration Number: NCT01089478

Study of Cells From Spinal Cavity of Patients With Low Back Pain

Withdrawn

Conditions: Low Back Pain

First Posted Date: 2010-03-18

Last Posted Date: 2015-05-12

Lead Sponsor: Texas Tech University Health Sciences Center

Registration Number: NCT01089491

Locations: 🇺🇸
Texas Tech University Health Sciences Center, Lubbock, Texas, United States

Effect of Weight and/or Obesity on Caspofungin Drug Concentrations

Phase 4

Completed

Conditions: Fungal Infection
Obesity

Interventions: Drug: Caspofungin

First Posted Date: 2010-02-04

Last Posted Date: 2017-02-10

Lead Sponsor: Texas Tech University Health Sciences Center

Target Recruit Count: 18

Registration Number: NCT01062165

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy